Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

(2011) J. R. Banegas et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update

(2011) Lori Mosca et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adherence and persistence with taking medication to control high blood pressure

(2011) Martha N. Hill et al.   Journal of the American Society of Hypertension

Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey

(2010) Željko Reiner et al.   ATHEROSCLEROSIS

Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

(2010) Massimo Francesco Piepoli et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

(2010) Komelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Adding The Patient Perspective To Comparative Effectiveness Research

(2010) Albert W. Wu et al.   HEALTH AFFAIRS

Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol

(2010) Ozgur Bayturan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

(2010) Philip Greenland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

JUPITER, rosuvastatin, and the European Medicines Agency

(2010) Paul M Ridker et al.   LANCET

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Public perceptions of cardiovascular risk factors in Croatia: The PERCRO survey

(2010) Željko Reiner et al.   PREVENTIVE MEDICINE

Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

(2009) José R. Banegas et al.   AMERICAN JOURNAL OF MEDICINE

The impact of smokefree legislation in Scotland: results from the Scottish ITC Scotland/UK longitudinal surveys

(2009) A. Hyland et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

A Closer Look at the Economic Argument for Disease Prevention

(2009) Steven H. Woolf   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?

(2009) Alberto Zanchetti   JOURNAL OF HYPERTENSION

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries

(2009) Marta Pereira et al.   JOURNAL OF HYPERTENSION

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

How to improve cardiovascular diseases prevention in Europe?

(2009) Ž. Reiner   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease

(2008) P. Michael Ho et al.   ARCHIVES OF INTERNAL MEDICINE

A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus

(2008) Donna L. McLean   ARCHIVES OF INTERNAL MEDICINE

Developing performance indicators for primary care: Walsall's experience

(2008) Narinder Sahota et al.   BRITISH JOURNAL OF GENERAL PRACTICE

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Drugs for Cardiovascular Disease Prevention in Women

(2008) Nanette K Wenger   DRUGS

Developing the utility of blood biomarker associations beyond population sample linkage to events in cardiovascular patients

(2008) R. J. MacFadyen et al.   EUROPEAN HEART JOURNAL

Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice

(2008) Sue Wells et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models

(2008) L. Wilhelmsen et al.   JOURNAL OF INTERNAL MEDICINE

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE